Company | Background | Management | Advisors
Theresa Deisher, Ph.D. | Christopher P. Brown | Marissa LaMadrid, Ph.D. | Mark Ungs, MBA

Mark Ungs, MBA
Business Development Director

Mark Ungs recently served as the Vice President of New Business Development for Boston Scientific’s multi-billion dollar Interventional Cardiology division where he was responsible for leading the division’s growth outside its core businesses through internal development programs as well as external technology acquisitions into new therapies. While at BSC, Mr. Ungs chartered and managed more than 15 licensing/acquisition deals representing over $750 million in committed capital.

Mr.Ungs has played key roles in launching the two largest commercial successes in the history of the medical device industry, the drug coated stent and cardiac resynchronization therapy for congestive heart failure, representing billions in incremental revenue for his employers.

Mr. Ungs has over twenty years professional experience in the medical device industry. He has a degree in Chemical Engineering from Oregon State University and an MBA from the University of California, Berkeley.

Home|Background|Management|Advisors|Vaccines|Regenerative Medicine|Media|Research|Words of Support |Contact

Disclaimer | AVM Biotechnology | Eklind Hall | 1102 Columbia Street, Suite 316 | Seattle, WA 98104 | 206-906-9922| | © Copyright 2010 AVM Biotechnology, LLC